top of page
![](https://static.wixstatic.com/media/11062b_95d34f15761e4114a57b17823228948ef000.jpg/v1/fill/w_288,h_162,al_c,q_80,usm_0.66_1.00_0.01,blur_2,enc_auto/11062b_95d34f15761e4114a57b17823228948ef000.jpg)
![SeqOnce](https://static.wixstatic.com/media/09b971_e7fc4ddd657b4dde9e36d5bbee602a1c~mv2.png/v1/fill/w_504,h_284,al_c,q_85,usm_0.66_1.00_0.01,enc_auto/Image-empty-state.png)
Accelerating next-gen sequencing & diagnostics
INVESTMENt
October, 2018
Sector
Science
FUND
Fund 1
location
Southern California
co-investors
Mount Wilson Ventures
Embark Ventures
InAmerica Ventures
![Sonia Szamocki 32co ceo](https://static.wixstatic.com/media/09b971_0bbdcc1c3491467fa07bc91ec86ea6af~mv2.jpeg/v1/fill/w_405,h_402,al_c,lg_1,q_80,enc_auto/Image-empty-state_edited.jpeg)
![Alertive.png](https://static.wixstatic.com/media/328513_487353f1d679434db23dbc73737e2801~mv2.png/v1/fill/w_109,h_109,al_c,q_85,usm_0.66_1.00_0.01,blur_2,enc_auto/Alertive.png)
Quintuple aim
![](https://static.wixstatic.com/media/813b164e6ecd49b0b09f5f9913d34577.jpg/v1/fill/w_123,h_82,al_c,q_80,usm_0.66_1.00_0.01,blur_2,enc_auto/813b164e6ecd49b0b09f5f9913d34577.jpg)
SeqOnce is accelerating life science discoveries and improving patient outcomes by focusing on Next-Gen Sequencing for genomics and diagnostics. SeqOnce’s proprietary technology uses a unique set of enzymatic reactions to reduce reaction steps and reagents. The result is a sample library prep kit that is fast, easy to use, and produces high-quality libraries regardless of sample source or application.
bottom of page